Week In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company
April 29, 2017 at 14:45 PM EDT
Cathay Fortune International, a Shanghai healthcare private equity firm, will acquire Berlin's Epigenomics AG for $186 million in cash. Cathay will acquire Epigenomics through a subsidiary, Blitz F16-83.